Anti-GD2 Antibody (Naxitamab)
Catalog No.
F1501
Anti-GD2 Antibody (Naxitamab)
Featured Products
Naxitamab (Hu3F8) is a humanized monoclonal antibody targeting GD2 (hu3F8). Naxitamab is used in the study of neuroblastoma, osteosarcoma, and other GD2-positive cancers.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.38 kDa
Dry ice
1879925-92-4
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Naxitamab-gqgk, DANYELZA, Hu3F8
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
GD2
Please avoid freeze-thaw cycles.